361 Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

361 Capital’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-93,561	Closed	-$1.96M	–	414
2018 Q2	$1.96M	Buy	+93,561	New	+$1.73M	0.44%	46

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

361 Capital's SPPI Position: Q3 2018 in Review

361 Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2018, closing a stake of 93,561 shares — an estimated $1.96M sold.

361 Capital first reported a position in SPPI in Q2 2018 and held it in 1 quarter. The position peaked at $1.96M in Q2 2018. 190 funds tracked by Wall St. Rank hold SPPI as of Q3 2018.

361 Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
361 Capital sold 93,561 Spectrum Pharmaceuticals Inc shares in Q3 2018, an estimated $1.96M.
361 Capital first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 1 quarter.
361 Capital's Spectrum Pharmaceuticals Inc position peaked at $1.96M in Q2 2018.
190 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2018.

Based on 361 Capital's 13F filing for Q3 2018, filed 13 Nov 2018.